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The majority of breast cancers originate in the mammary
ducts. As such many diagnostic techniques introduce mm-
diameter devices into the ducts through the nipple. Estab-
lished intraductal techniques include ductal lavage, and
white-light or fluorescence endoscopy. While reported
values vary, these techniques typically suffer from low
sensitivity and specificity. Similarly, Magnetic Resonance
Imaging (MRI) for breast oncology suffers a high rate of
false positives. Magnetic resonance (MR) spectroscopy is
highly effective in distinguishing between benign and
malignant tissue. However, clinical relevance is limited to
late-stage of disease due to a required cubic-centimeter
volume for diagnosis. Small-volume sensitivity for spec-
troscopy and imaging is possible through use of a minia-
ture radio-frequency (RF) coil. An intraductal RF
microcoil reduces the required volume of diseased tissue
to a cubic-millimeter, bringing spectroscopy to early
stages of early diagnosis. Micro-scale images from an
intraductal microcoil may enable high-precision localiza-
tion of tumors and tumor margins. The microcoil catheter
was designed with an approximate diameter of 1 mm for
intraductal use and for possible integration with ductos-
copes. Experimental verification of the first-generation
coil-design was achieved through ex vivo MR imaging of
tissue. As expected, the microcoil provided microscale
images. While 3-T (128 MHz) MRI typically provides 1 to
30 voxels per-cubic-mm the MRI microcoil can provide
hundreds, and even thousands of voxels in the same vol-
ume. The first generation microcoil consisted of a 1-mm-
diameter solenoid with 4.5 turns, spaced 0.05 mm apart,
leading to 25-mm long parallel leads, with one of the
leads passing through the center of the solenoid. A crucial
requirement for optimal MR coil design is a homogenous
magnetic field generated in the coil. Unfortunately, the
central conductor inside the solenoid of the original
microcoil greatly disturbed the homogeneity of the mag-
netic-field. The parallel-leads of the first generation device
correspond to a popular catheter-coil geometry, a single-
loop coil. The parallel leads therefore collect unwanted
signal, in other words noise. The new design overcomes
both of these flaws. Turn-spacing of the first microcoil
design was intended for optimizing the signal collected
from the center of the solenoid. However, since the target
tissue is at the tip of the solenoid, the new design is opti-
mized for our target tissue with ten turns separated by the
thin insulation of the wire. The turn-spacing of the first
generation microcoil was controlled by a thick layer of
insulation that also provided a good barrier from the
body. Due to the lack of a thick insulator, the second gen-
eration-design required a new configuration for isolating
the coil from the body to prevent degradation of the per-
formance over time. We analyzed the stability of the new
microcoils by soaking 5 microcoils in body temperature
saline and measuring the impedance at 128 MHz over
time. The impedance of the microcoils remained constant
for nearly 2 hours, and increased only slightly after 4
hours. Preliminary heating experiments indicate that little
to no heating occurs during use of the microcoil as an MR
transceiver. Initial imaging results confirm that the second
generation microcoil improves greatly on the first genera-
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tion coils, with significantly less imaging artifacts despite
having twice the lead length.
Recent success by Dr. Love with intraductal chemotherapy
application intensifies the need for early diagnosis. A
microcoil may provide spectroscopic evidence of cancer.
Microcoil images may show if the malignancy has
breached the ductal lining. The open lumen of the intra-
ductal microcoil enables clinicians to target sub-branches
of ducts with chemotherapy.